Report Shows Record Number of Cancer Drugs in Development
Responding to President Obama’s call for “a cure for cancer in our time,” the Pharmaceutical Research and Manufacturers of America recently delivered a new report on drugs in the research pipeline for cancer.
Responding to President Obama's call for "a cure for cancer in our time," the Pharmaceutical Research and Manufacturers of America recently delivered a new report on drugs in the research pipeline for cancer. The report shows that America's pharmaceutical research and biotechnology companies are testing a record 861 new cancer medicines and vaccines. The drugs listed in the report are being tested in human clinical trials or are awaiting approval by the US Food and Drug Administration.
Efficacy and Safety of Zolbetuximab in Gastric Cancer
Zolbetuximab’s targeted action, combined with manageable adverse effects, positions it as a promising therapy for advanced gastric cancer.
These data support less restrictive clinical trial eligibility criteria for those with metastatic NSCLC. This is especially true regarding both targeted therapy and immunotherapy treatment regimens.
